MET signalling: principles and functions in development, organ regeneration and cancerLivio Trusolino, Paolo M. Comoglio|Nature Reviews Molecular Cell Biology|2010Cited by 1.2k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trialAndrea Sartore‐Bianchi, Salvatore Siena, Cosimo Martino et al.|The Lancet Oncology|2016Cited by 1k
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.Luigi Naldini, Paolo M. Comoglio|The EMBO Journal|1992Cited by 565
Ron Kinase Transphosphorylation Sustains <i>MET</i> Oncogene AddictionSilvia Benvenuti, Paolo M. Comoglio|Cancer Research|2011Cited by 72